» Articles » PMID: 19093929

The Aggressive Behavior Scale: a New Scale to Measure Aggression Based on the Minimum Data Set

Overview
Specialty Geriatrics
Date 2008 Dec 20
PMID 19093929
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To examine the reliability and validity of the Aggressive Behavior Scale (ABS), derived from the Minimum Data Set (MDS 2.0).

Design: Retrospective analysis of MDS 2.0 and Cohen Mansfield Agitation Inventory (CMAI) data.

Setting: Ontario nursing homes (NHs) and complex continuing care (CCC) hospitals and units.

Participants: Two hundred fourteen patients of a CCC hospital, 652 residents of four NH facilities who adopted the MDS 2.0 before its mandatory implementation, 124,259 CCC patients assessed with the MDS 2.0 between July 1996 and October 2006.

Measurements: In all samples, trained facility clinical staff completed the MDS 2.0 as part of normal clinical practice. The ABS is a 4-item summary scale measuring verbal and physical abuse, socially inappropriate behavior, and resisting care. In the single CCC facility, clinical facility staff completed the CMAI during the same assessment period as the MDS 2.0.

Results: Alphas for the ABS were between 0.79 and 0.93 for the three samples. A strong relationship was found between the ABS and the aggressive subscale of the CMAI (correlation coefficient=0.72, P<.001). Impairment in cognition was found to be related to higher ABS scores in all three samples. In CCC, individuals who had higher ABS scores also had a higher prevalence of psychiatric diagnoses and greater frequency of daily restraint use (P<.001 for each dependent variable).

Conclusion: The ABS provides a useful measure of the severity of aggressive behavior that can be used for care planning, quality measurement, and research.

Citing Articles

Bilateral hypothalamotomy plus dominant amygdalotomy with Gamma Knife radiosurgery. A non-invasive alternative when everything has failed in the management of aggressive behavior disorder.

Romero O, Diez-Palma J, Fonnegra-Caballero A, Segura-Hernandez A, Matinez-Alvarez R, Yamhure E Surg Neurol Int. 2025; 15():469.

PMID: 39777183 PMC: 11704447. DOI: 10.25259/SNI_860_2024.


Antipsychotic Medication Use Among Newly Admitted Long-term Care Residents During the COVID-19 Pandemic in Canada.

Turcotte L, Heckman G, McArthur C, Saari M, Sinn C, Mathias K Health Serv Insights. 2024; 17:11786329241300827.

PMID: 39619866 PMC: 11607760. DOI: 10.1177/11786329241300827.


EXploring Patterns of Use and Effects of Adult Day Programs to Improve Trajectories of Continuing Care (EXPEDITE): Protocol for a Retrospective Cohort Study.

Hoben M, Maxwell C, Ubell A, Doupe M, Goodarzi Z, Allana S JMIR Res Protoc. 2024; 13:e60896.

PMID: 39213024 PMC: 11399746. DOI: 10.2196/60896.


Assessing behavioral and psychological symptoms of dementia: a comprehensive review of current options and future perspectives.

Pozzi F, Cali L, Ferrarese C, Appollonio I, Tremolizzo L Front Dement. 2024; 2:1226060.

PMID: 39082001 PMC: 11285590. DOI: 10.3389/frdem.2023.1226060.


Detecting agitation and aggression in persons living with dementia: a systematic review of diagnostic accuracy.

Wong B, Wu P, Ismail Z, Watt J, Goodarzi Z BMC Geriatr. 2024; 24(1):559.

PMID: 38926638 PMC: 11210082. DOI: 10.1186/s12877-024-05143-6.